This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1984 Jan;14(1):109-12.

doi: 10.1007/BF01966842.

Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective

G de Gaetano, V Bertelé

PMID: 6702507
DOI: 10.1007/BF01966842

Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective

G de Gaetano et al. Agents Actions. 1984 Jan.

. 1984 Jan;14(1):109-12.

doi: 10.1007/BF01966842.

Authors

G de Gaetano, V Bertelé

PMID: 6702507
DOI: 10.1007/BF01966842

No abstract available

PubMed Disclaimer

Similar articles

Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
Hanson SR, Harker LA. Hanson SR, et al. Ann N Y Acad Sci. 1983;416:642-50. doi: 10.1111/j.1749-6632.1983.tb35217.x. Ann N Y Acad Sci. 1983. PMID: 6587821 No abstract available.
The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H. Sugidachi A, et al. Br J Pharmacol. 2000 Apr;129(7):1439-46. doi: 10.1038/sj.bjp.0703237. Br J Pharmacol. 2000. PMID: 10742300 Free PMC article.
Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis.
Bernat A, Vallée E, Maffrand JP, Roncucci R. Bernat A, et al. Thromb Res. 1985 Jan 15;37(2):279-85. doi: 10.1016/0049-3848(85)90016-7. Thromb Res. 1985. PMID: 3975872
Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
Picard-Fraire C. Picard-Fraire C. Thromb Res Suppl. 1983;4:119-28. doi: 10.1016/0049-3848(83)90367-5. Thromb Res Suppl. 1983. PMID: 6356462 Review.
The mechanisms of action of ticlopidine.
Bruno JJ. Bruno JJ. Thromb Res Suppl. 1983;4:59-67. doi: 10.1016/0049-3848(83)90359-6. Thromb Res Suppl. 1983. PMID: 6356466 Review. No abstract available.

See all similar articles

Cited by

Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C, Mancini M. Di Minno G, et al. J Clin Invest. 1985 Feb;75(2):328-38. doi: 10.1172/JCI111705. J Clin Invest. 1985. PMID: 3156146 Free PMC article.
Current issues in thrombosis prevention with antiplatelet drugs.
de Gaetano G, Cerletti C, Dejana E, Vermylen J. de Gaetano G, et al. Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004. Drugs. 1986. PMID: 3525085 Review.
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.
Saltiel E, Ward A. Saltiel E, et al. Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003. Drugs. 1987. PMID: 3304967 Review.

References

1. Lancet. 1981 Nov 7;2(8254):1018-20 - PubMed
1. Thromb Res. 1978 Aug;13(2):245-54 - PubMed
1. N Engl J Med. 1977 Dec 8;297(23):1284-5 - PubMed
1. Pharmacol Rev. 1978 Sep;30(3):293-331 - PubMed
1. J Clin Invest. 1977 Sep;60(3):535-45 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information